TITLE:
Clinical and Therapeutic Aspects of Giant Fibroids at the Hôpital du Mali about 30 Cases
AUTHORS:
Mamadou B. Coulibaly, Alassane Traore, Mody A. Camara, Abdrahamane Togo, Adama Sangaré, Issa Ongoiba, Kalba Timbine, Amadou Sidibé, Apérou Guindo, Niani Mounkoro, Ibrahim Teguete, Youssouf Traore, Moustaphe Toure
KEYWORDS:
Giant Fibroma, Care, Surgery, Hôpital du Mali
JOURNAL NAME:
Open Journal of Obstetrics and Gynecology,
Vol.10 No.6,
June
11,
2020
ABSTRACT: The fibroids affect 20% to 25%
of women of reproductive age and are 3 to 9 times more common in black women.
We’ll talk about giant fibroids (GFs) when uterine height reaches or exceeds
the navel. We have initiated this study in order to report the epidemioclinical
and therapeutic aspects of giant fibroids at the Hopital du Mali. A descriptive
retro-prospective study, conducted in the service of gynecology of the Hopital
du Mali from November 2017 to December 2018 were included in this study, any
patients, regardless of their age, having developed a fibroid, the uterin
e
height of the patient reaching or exceeding the umbilicus on physical
examination and who were on surgical treatment. We had collected 30 cases of
GFs out of the 92 patients who had undergone myomectomies, with a frequency of
32.60%. The age group 25 - 29 years accounted for
46.6% with an average age of 35 years. Housewives represented 50% and
nulligravida made up 33% of our patients. Desire to become pregnant was the
main reason for consultation in 34.4% of cases. The uterine height was between
25 and 29 cm on physical examination in 46.66% of cases. Myomectomy was
performed in 76.64% and hysterectomy in 23.3% of cases. The size of the nuclei
after surgery was over 25 cm in
48.66% of our patients. Conclusion: The giant fibroid (GF) is a common cause of myomectomy. The treatment
is either hysterectomy or myomectomy and depends on the indications.